FDA Import Refusal AEK-8221015-2/11/1 — Novartis Pharmaceuticals Canada Inc.
The FDA refused shipment AEK-8221015-2/11/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Mar 4, 2025. The refused product falls under Drugs and Biologics — OMALIZUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 4, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58ACY04 OMALIZUMAB
- Charges
- 75